论文部分内容阅读
艾司洛尔作为一种超短效的选择性β1 受体阻滞剂 ,由于其起效迅速、作用持续时间短 ,被广泛用于防治气管插管所致的心血管反应[1～ 3] 。对心肺功能尚好患者的室上性心律失常也具有较高的疗效和安全性[4～ 7] 。本文旨在观察心肺功能衰竭并发室上性心律失常患者静注艾司洛尔的
Esmolol, as an ultra-short-acting, selective β1-blocker, is widely used to prevent and treat cardiovascular reactions caused by endotracheal intubation due to its rapid onset and short duration of action [1-3] . Supraventricular cardiac arrhythmia in patients with good cardiopulmonary function also has a high efficacy and safety [4 ~ 7]. This article aims to observe the cardiopulmonary failure patients with supraventricular arrhythmia intravenous esmolol